Bikbov, Mukharram M.,
Zainullin, Rinat M.,
Gilmanshin, Timur R.,
Iakupova, Ellina M.,
Kazakbaeva, Gyulli M.,
Panda-Jonas, Songhomitra,
Tuliakova, Azaliia M.,
Fakhretdinova, Albina A.,
Gilemzianova, Leisan I.,
Jonas, Jost B. (2023) prevalence of non-alcoholic
fatty liver disease, lower depression score and lower prevalence of arthritis
Sufianov, Albert,
Beilerli, Aferin,
Kudriashov, Valentin,
Ilyasova, Tatiana,
Wenjie, Bu,
Beylerli, Ozal (2023) and to defend the genome from invasive nucleic
acids. The use of siRNAs has been studied as a treatment option
Bogdanov, Andrei V.,
Neganova, Margarita,
Voloshina, Alexandra,
Lyubina, Anna,
Amerhanova, Syumbelya,
Litvinov, Igor A.,
Tsivileva, Olga,
Akylbekov, Nurgali,
Zhapparbergenov, Rakhmetulla,
Valiullina, Zulfiia,
Samorodov, Alexandr V.,
Alabugin, Igor (2023) into water-soluble isatin-3-hydrazones using their
acid-catalyzed reaction with Girard’s reagent P and its
Пути развития иммунотерапии колоректального рака with inhibitors of histone methyltransferases and deoxyribonucleic
acids (DNA) leads to the formation of double